COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
COVID-19
SARS-CoV-2
acute leukemia
hematological malignancies
lymphoma
multiple myeloma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 Feb 2023
27 Feb 2023
Historique:
received:
30
11
2022
revised:
30
01
2023
accepted:
01
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
Mortality rates for COVID-19 have declined over time in the general population, but data in patients with hematologic malignancies are contradictory. We identified independent prognostic factors for COVID-19 severity and survival in unvaccinated patients with hematologic malignancies, compared mortality rates over time and versus non-cancer inpatients, and investigated post COVID-19 condition. Data were analyzed from 1166 consecutive, eligible patients with hematologic malignancies from the population-based HEMATO-MADRID registry, Spain, with COVID-19 prior to vaccination roll-out, stratified into early (February-June 2020;
Identifiants
pubmed: 36900296
pii: cancers15051497
doi: 10.3390/cancers15051497
pmc: PMC10001264
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Crit Care Med. 2021 Feb 1;49(2):209-214
pubmed: 33105150
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Blood Adv. 2020 Dec 8;4(23):5966-5975
pubmed: 33278301
J Hosp Med. 2021 Feb;16(2):90-92
pubmed: 33147129
Front Public Health. 2021 Mar 19;9:652842
pubmed: 33816427
Exp Hematol Oncol. 2020 Aug 25;9:21
pubmed: 32864192
Br J Haematol. 2022 Feb;196(4):892-901
pubmed: 34761389
Br J Haematol. 2020 Sep;190(5):e279-e282
pubmed: 32526039
BMC Infect Dis. 2022 Mar 3;22(1):211
pubmed: 35240997
Lancet. 2020 Jun 20;395(10241):1919-1926
pubmed: 32473682
Blood. 2021 Nov 4;138(18):1768-1773
pubmed: 34297826
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
JAMA Intern Med. 2021 Apr 1;181(4):471-478
pubmed: 33351068
JAMA Netw Open. 2021 Oct 1;4(10):e2128568
pubmed: 34643720
Lancet Oncol. 2021 Dec;22(12):1669-1680
pubmed: 34741822
Lancet Reg Health Eur. 2021 Jun;5:100104
pubmed: 33969337
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Blood Cancer J. 2021 Jun 16;11(6):115
pubmed: 34135309
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32245835
Cancer Cell. 2020 Nov 9;38(5):661-671.e2
pubmed: 32997958
J Hematol Oncol. 2020 Oct 8;13(1):133
pubmed: 33032660
Blood. 2020 Dec 17;136(25):2881-2892
pubmed: 33113551
Rev Clin Esp (Barc). 2020 Nov;220(8):480-494
pubmed: 32762922
JAMA Oncol. 2022 Jan 1;8(1):69-78
pubmed: 34709356
Lancet Haematol. 2020 Oct;7(10):e737-e745
pubmed: 32798473
J Hematol Oncol. 2021 Oct 14;14(1):168
pubmed: 34649563
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99
pubmed: 33476315